Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice

Patients suffering from opioid use disorder often relapse during periods of abstinence, which is posited to be caused by negative affective states that drive motivated behaviors. Here, we explored whether conditioning mice with morphine in a conditioned place preference (CPP) training paradigm evoke...

Full description

Bibliographic Details
Main Authors: Greer McKendrick, Hannah Garrett, Holly E. Jones, Dillon S. McDevitt, Sonakshi Sharma, Yuval Silberman, Nicholas M. Graziane
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Behavioral Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fnbeh.2020.00075/full
_version_ 1818963908846682112
author Greer McKendrick
Greer McKendrick
Hannah Garrett
Holly E. Jones
Holly E. Jones
Dillon S. McDevitt
Dillon S. McDevitt
Sonakshi Sharma
Yuval Silberman
Nicholas M. Graziane
author_facet Greer McKendrick
Greer McKendrick
Hannah Garrett
Holly E. Jones
Holly E. Jones
Dillon S. McDevitt
Dillon S. McDevitt
Sonakshi Sharma
Yuval Silberman
Nicholas M. Graziane
author_sort Greer McKendrick
collection DOAJ
description Patients suffering from opioid use disorder often relapse during periods of abstinence, which is posited to be caused by negative affective states that drive motivated behaviors. Here, we explored whether conditioning mice with morphine in a conditioned place preference (CPP) training paradigm evoked anxiety-like behavior during morphine abstinence. To do this, mice were conditioned with morphine (10 mg/kg, i.p.) for 5 days. Twenty-four hours following conditioning, anxiety levels were tested by measuring time in the open arms of the elevated plus-maze. The next day, mice were placed in the three-compartment chamber to measure morphine-induced CPP. Our results show that following morphine conditioning, mice spent significantly less time in the open arm of the elevated plus-maze and expressed robust morphine CPP on CPP test day. Furthermore, we found that an acute treatment with (R,S)-ketamine (10 mg/kg, i.p.), a medication demonstrating promise for preventing anxiety-related phenotypes, 30 min before testing on post-conditioning day 1, increased time spent in the open arm of the elevated plus-maze in saline- and morphine-conditioned mice. Additionally, we found that the second injection of ketamine 30 min before CPP tests on post-conditioning day 2 prevented morphine-induced CPP, which lasted for up to 28 days post-conditioning. Furthermore, we found that conditioning mice with 10% (w/v) sucrose using an oral self-administration procedure did not evoke anxiety-like behavior, but elicited robust CPP, which was attenuated by ketamine treatment 30 min before CPP tests. Overall, our results suggest that the ketamine-induced block of morphine CPP may not be attributed solely to alleviating negative affective states, but potentially through impaired memory of morphine-context associations.
first_indexed 2024-12-20T12:52:42Z
format Article
id doaj.art-a14a8ae4988f4a39812a0afd5f8ad1f4
institution Directory Open Access Journal
issn 1662-5153
language English
last_indexed 2024-12-20T12:52:42Z
publishDate 2020-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Behavioral Neuroscience
spelling doaj.art-a14a8ae4988f4a39812a0afd5f8ad1f42022-12-21T19:40:09ZengFrontiers Media S.A.Frontiers in Behavioral Neuroscience1662-51532020-05-011410.3389/fnbeh.2020.00075525531Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in MiceGreer McKendrick0Greer McKendrick1Hannah Garrett2Holly E. Jones3Holly E. Jones4Dillon S. McDevitt5Dillon S. McDevitt6Sonakshi Sharma7Yuval Silberman8Nicholas M. Graziane9Neuroscience Graduate Program, Penn State College of Medicine, Hershey, PA, United StatesDepartment of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, PA, United StatesDepartment of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, PA, United StatesDepartment of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, PA, United StatesSummer Undergraduate Research Internship Program, Penn State College of Medicine, Hershey, PA, United StatesNeuroscience Graduate Program, Penn State College of Medicine, Hershey, PA, United StatesSummer Undergraduate Research Internship Program, Penn State College of Medicine, Hershey, PA, United StatesDepartment of Anesthesiology and Perioperative Medicine, Penn State College of Medicine, Hershey, PA, United StatesDepartment of Neural and Behavioral Sciences, Penn State College of Medicine, Pennsylvania State University, Hershey, PA, United StatesDepartments of Anesthesiology and Perioperative Medicine and Pharmacology, Penn State College of Medicine, Hershey, PA, United StatesPatients suffering from opioid use disorder often relapse during periods of abstinence, which is posited to be caused by negative affective states that drive motivated behaviors. Here, we explored whether conditioning mice with morphine in a conditioned place preference (CPP) training paradigm evoked anxiety-like behavior during morphine abstinence. To do this, mice were conditioned with morphine (10 mg/kg, i.p.) for 5 days. Twenty-four hours following conditioning, anxiety levels were tested by measuring time in the open arms of the elevated plus-maze. The next day, mice were placed in the three-compartment chamber to measure morphine-induced CPP. Our results show that following morphine conditioning, mice spent significantly less time in the open arm of the elevated plus-maze and expressed robust morphine CPP on CPP test day. Furthermore, we found that an acute treatment with (R,S)-ketamine (10 mg/kg, i.p.), a medication demonstrating promise for preventing anxiety-related phenotypes, 30 min before testing on post-conditioning day 1, increased time spent in the open arm of the elevated plus-maze in saline- and morphine-conditioned mice. Additionally, we found that the second injection of ketamine 30 min before CPP tests on post-conditioning day 2 prevented morphine-induced CPP, which lasted for up to 28 days post-conditioning. Furthermore, we found that conditioning mice with 10% (w/v) sucrose using an oral self-administration procedure did not evoke anxiety-like behavior, but elicited robust CPP, which was attenuated by ketamine treatment 30 min before CPP tests. Overall, our results suggest that the ketamine-induced block of morphine CPP may not be attributed solely to alleviating negative affective states, but potentially through impaired memory of morphine-context associations.https://www.frontiersin.org/article/10.3389/fnbeh.2020.00075/fullnegative affectmorphineconditioned place preferenceanxietyopioid use disorderketamine
spellingShingle Greer McKendrick
Greer McKendrick
Hannah Garrett
Holly E. Jones
Holly E. Jones
Dillon S. McDevitt
Dillon S. McDevitt
Sonakshi Sharma
Yuval Silberman
Nicholas M. Graziane
Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice
Frontiers in Behavioral Neuroscience
negative affect
morphine
conditioned place preference
anxiety
opioid use disorder
ketamine
title Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice
title_full Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice
title_fullStr Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice
title_full_unstemmed Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice
title_short Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice
title_sort ketamine blocks morphine induced conditioned place preference and anxiety like behaviors in mice
topic negative affect
morphine
conditioned place preference
anxiety
opioid use disorder
ketamine
url https://www.frontiersin.org/article/10.3389/fnbeh.2020.00075/full
work_keys_str_mv AT greermckendrick ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT greermckendrick ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT hannahgarrett ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT hollyejones ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT hollyejones ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT dillonsmcdevitt ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT dillonsmcdevitt ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT sonakshisharma ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT yuvalsilberman ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice
AT nicholasmgraziane ketamineblocksmorphineinducedconditionedplacepreferenceandanxietylikebehaviorsinmice